NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE4717 Query DataSets for GSE4717
Status Public on Nov 03, 2006
Title 5`aza-dC demethylation of three short term cultured glioblastomas
Organism Homo sapiens
Experiment type Expression profiling by array
Methylation profiling by array
Summary Glioblastoma, the most aggressive and least treatable form of malignant glioma, is the most common human brain tumor. Although many regions of allelic loss occur in glioblastomas, relatively few tumor suppressor genes have been found mutated at such loci. To address the possibility that epigenetic alterations are an alternative means of glioblastoma gene inactivation, we coupled pharmacological manipulation of methylation with gene profiling to identify potential methylation-regulated, tumor-related genes. Triplicates of three short-term cultured glioblastomas were exposed to 5μM 5-aza-dC for 96 hours followed by cRNA hybridization to an oligonucleotide microarray (Affymetrix U133A). We based candidate gene selection on bioinformatics, RT-PCR, bisulfite sequencing, methylation-specific PCR and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Two genes identified in this manner, RUNX3 and Testin (TES), were subsequently shown to harbor frequent tumor-specific epigenetic alterations in primary glioblastomas. This overall approach therefore provides a powerful means to identify candidate tumor suppressor genes for subsequent evaluation and may lead to the identification of genes whose epigenetic dysregulation is integral to glioblastoma tumorigenesis.
Keywords: expression profile following global demethylation
 
Overall design Duplicates of three short term cultured glioblastoma cell lines (internal IDs: GLI56;GLI60;GLI72) were either exposed to 5umol 5`aza-dC for 96h or left untreated. Total RNA was extracted of treated and untreated cells after 96h and hybridized to U133A chip. Gene expression profiles of treated and untreated cells were compared. Upregulation of gene expression in the treated (demethylated) samples was interpreted as potentially being regulated by methylation - pointing towards hypermethylation in the related cell line. Identification of novel tumor suppressor genes, regulated by methylation, was the overall goal.
 
Contributor(s) Mueller WC, Louis DN
Citation(s) 16909125
Submission date Apr 25, 2006
Last update date Aug 10, 2018
Contact name Wolf C Mueller
E-mail(s) wolf_muller@yahoo.de, wolf.mueller@charite.de
Phone +49-(0)30-450536004
Fax +49-(0)30-450536940
Organization name Charité Universitätsmedizin Berlin
Department Neuropathology
Street address Amrumer Str. 1
City Berlin
ZIP/Postal code 13353
Country Germany
 
Platforms (1)
GPL96 [HG-U133A] Affymetrix Human Genome U133A Array
Samples (12)
GSM106370 short term cultured GBM_ID GLI56T1_5`aza-dc_96h_rep1
GSM106377 short term cultured GBM_ID GLI56T2_5`aza-dc_96h_rep2
GSM106398 short term cultured GBM_ID GLI60T1_5`aza-dc_96h_rep1
Relations
BioProject PRJNA95605

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary data files not provided

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap